PAULINA MALDONADO: Open Payments
NPI 1760810840 · LONG ISLAND CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,143 in 94 payments from 18 companies in 2025. Trend: 2023 $2,784 · 2024 $2,406 · 2025 $3,143
Food & beverage: $3,143
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $674 |
| Abbott Laboratories | 7 | $544 |
| Mannkind Corporation | 6 | $425 |
| Xeris Pharmaceuticals, Inc. | 17 | $372 |
| Lilly USA, LLC | 11 | $249 |
| Madrigal Pharmaceuticals | 5 | $241 |
| SANOFI-AVENTIS U.S. LLC | 5 | $128 |
| Insulet Corporation | 3 | $96 |
| ABBVIE INC. | 4 | $92 |
| TOLMAR, INC. | 4 | $91 |
Products named: FREESTYLE LIBRE 3, AFREZZA, Ozempic, REZDIFFRA, RECORLEV, MOUNJARO, JARDIANCE, GVOKE HYPOPEN.
Industry payments across NY — which companies pay providers there.
